Management and mortality in patients with non-ST-segment elevation vs. ST-segment elevation myocardial infarction. Data from the malopolska registry of acute coronary syndromes

Kardiologia Polska

Volumn 67, Issue 2, 2009, Pages 115-120

  Dziewierz, Artur ^a   Siudak, Zbigniew ^a   Dykla, Dominika ^a   Rakowski, Tomasz ^a   Mielecki, Waldemar ^a   Dubiel, Jacek S ^a   Dudek, Dariusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Management; Mortality; Myocardial infarction; Pharmacotherapy

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH CARE FACILITY; HEART FAILURE; HOSPITAL MANAGEMENT; HOSPITALIZATION; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NON INVASIVE PROCEDURE; REGISTER; ST SEGMENT ELEVATION;

EID: 64649090856     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 2007; 116: 2634-53.
2. Silber S, Albertsson P, Avilés FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26: 804-47.
3. Van De Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003; 24: 28-66.
4. Bassand JP, Hamm CW, Ardissino D. The Task Force for the Diagnosis and Treatment of Non-ST-segment Elevation Acute Coronary Syndromes of the ESC. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1598-660.
5. Dudek D, Siudak Z, Kuta M, et al. Management ofmyocardial infarction with ST-segment elevation in district hospitals without catheterisation laboratory - Acute Coronary Syndromes Registry of Malopolska 2002- 2003. Kardiol Pol 2006; 64: 1053-60.
6. Dudek D, Siudak Z, Dziewierz A, et al. Local hospital networks for STEMI treatment for a population of half amillion inhabitants increase the use of invasive treatment of acute coronary syndromes to the European recommended level. The Małopolska Registry of Acute Coronary Syndromes 2005-2006. Kardiol Pol 2008; 66: 489-97.
7. Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416.
8. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002; 90: 358-63.
9. Montalescot G, Dallongeville J, Van BE, et al. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J 2007; 28: 1409-17.
10. Abbott JD, Ahmed HN, Vlachos HA, et al. Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 2007; 100: 190-5.
11. Terkelsen CJ, Lassen JF, Norgaard BL, et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J 2005; 26: 18-26.
12. Abbas AE, Boura JA, Brewington SD, et al. Acute angiographic analysis of non-ST-segment elevation acute myocardial infarction. Am J Cardiol 2004; 94: 907-9.
13. Cox DA, Stone GW, Grines CL, et al. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial). Am J Cardiol 2006; 98: 331-7.
14. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 1994; 89: 1545-56.
15. Holmes DRJr, Berger PB, Hochman JS, et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999; 100: 2067-73.
16. Jacobs AK, French JK, Col J, et al. Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK? J Am Coll Cardiol 2000; 36: 1091-6.
17. Salisbury AC, Reid KJ, Spertus JA. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol 2007; 99: 636-41.